Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
VERACYTE, INC. (VCYT)
|
Add to portfolio |
|
|
|
| Price: |
$55.04
| | Metrics |
| OS: |
72.8
|
M
| |
|
|
| Market cap: |
$4
|
B
| |
|
|
|
Net cash:
|
$191
|
M
| |
$2.63
|
per share
|
|
EV:
|
$3.81
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 296.5 | 219.5 | 117.5 | 120.4 | 92.0 | 72.0 | 90.5 | 49.5 |
| Revenue growth | 35.1% | 86.8% | -2.4% | 30.8% | 27.9% | -20.5% | 82.9% | 29.6% |
| Cost of goods sold | 7.8 | 74.4 | 41.5 | 36.5 | 33.1 | 28.2 | 25.5 | 21.5 |
| Gross profit | 288.7 | 145.1 | 76.0 | 83.8 | 58.9 | 43.8 | 65.1 | 28.0 |
| Gross margin | 97.4% | 66.1% | 64.7% | 69.7% | 64.0% | 60.8% | 71.9% | 56.6% |
| Sales and marketing | 97.6 | 79.8 | 52.4 | 53.7 | 41.3 | 32.3 | 28.2 | 25.3 |
| Research and development | | 29.8 | 17.2 | 14.9 | 14.8 | 13.9 | 15.3 | 12.8 |
| General and administrative | 76.5 | 101.4 | 36.7 | 29.0 | 24.0 | 23.1 | 23.8 | 22.6 |
| EBITA | -19.7 | -65.9 | -30.3 | -13.7 | -21.2 | -25.4 | -27.7 | -32.7 |
| EBITA margin | -6.7% | -30.0% | -25.8% | -11.4% | -23.0% | -35.4% | -30.6% | -66.0% |
| Amortization of intangibles | 21.4 | 16.0 | 5.1 | 1.4 | 1.1 | 1.1 | 1.1 | 0.8 |
| EBIT | -41.1 | -81.9 | -35.4 | -15.1 | -22.2 | -26.5 | -28.8 | -33.5 |
| EBIT margin | -13.9% | -37.3% | -30.1% | -12.6% | -24.2% | -36.9% | -31.8% | -67.6% |
| Pre-tax income | -36.4 | -81.6 | -34.9 | -12.6 | -23.0 | -31.0 | -31.4 | -33.7 |
| Income taxes | 0.1 | -6.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 7.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -36.6 | -75.6 | -34.9 | -12.6 | -23.0 | -31.0 | -31.4 | -33.7 |
| Net margin | -12.3% | -34.4% | -29.7% | -10.5% | -25.0% | -43.1% | -34.6% | -68.1% |
| |
| Diluted EPS | ($0.51) | ($1.11) | ($0.66) | ($0.27) | ($0.62) | ($0.91) | ($1.09) | ($1.30) |
| Shares outstanding (diluted) | 71.5 | 67.9 | 53.2 | 46.1 | 37.0 | 33.9 | 28.8 | 26.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|